NO920722L - Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser - Google Patents

Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser

Info

Publication number
NO920722L
NO920722L NO92920722A NO920722A NO920722L NO 920722 L NO920722 L NO 920722L NO 92920722 A NO92920722 A NO 92920722A NO 920722 A NO920722 A NO 920722A NO 920722 L NO920722 L NO 920722L
Authority
NO
Norway
Prior art keywords
treatment
chronic inflammatory
inflammatory disorders
procedure
patient
Prior art date
Application number
NO92920722A
Other languages
English (en)
Norwegian (no)
Other versions
NO920722D0 (no
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of NO920722D0 publication Critical patent/NO920722D0/no
Publication of NO920722L publication Critical patent/NO920722L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Treatment Of Sludge (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO92920722A 1989-08-25 1992-02-24 Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser NO920722L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898919321A GB8919321D0 (en) 1989-08-25 1989-08-25 Treatment of chronic inflammatory conditions
PCT/GB1990/001318 WO1991002542A1 (fr) 1989-08-25 1990-08-24 Traitement d'etats inflammatoires chroniques

Publications (2)

Publication Number Publication Date
NO920722D0 NO920722D0 (no) 1992-02-24
NO920722L true NO920722L (no) 1992-04-24

Family

ID=10662094

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920722A NO920722L (no) 1989-08-25 1992-02-24 Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser

Country Status (13)

Country Link
US (1) US5833996A (fr)
EP (1) EP0489072B1 (fr)
JP (1) JP2987197B2 (fr)
AT (1) ATE135588T1 (fr)
AU (1) AU644813B2 (fr)
CA (1) CA2065286C (fr)
DE (1) DE69026094T2 (fr)
DK (1) DK0489072T3 (fr)
FI (1) FI920795A0 (fr)
GB (2) GB8919321D0 (fr)
NO (1) NO920722L (fr)
WO (1) WO1991002542A1 (fr)
ZA (1) ZA906753B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene
GB9024320D0 (en) * 1990-11-08 1990-12-19 Univ London Treatment of uveitis
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
ES2171454T3 (es) 1993-06-04 2002-09-16 Whitehead Biomedical Inst Proteinas de estres y sus usos.
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
US7157089B1 (en) 1996-11-26 2007-01-02 Stressgen Biotechnologies Corporation Immune responses using compositions containing stress proteins
JP4358306B2 (ja) * 1996-12-18 2009-11-04 スタンフォード ルーク リミティド 免疫系のＴｈ２活性のダウン−レギュレーションのためのマイコバクテリア・ワクチン
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
RU2135196C1 (ru) * 1996-12-19 1999-08-27 Научно-исследовательский институт по изучению лепры Способ иммунопрофилактики экспериментальной лепрозной инфекции
EP0971735B1 (fr) * 1997-04-01 2008-03-19 Thomas Julius Borody Composition et procede servant a traiter la maladie intestinale inflammatoire
NZ538399A (en) 1997-08-05 2007-05-31 Nventa Biopharma Corp Fusion protein comprising an HPV E7 protein and a stress protein wherein the E7 protein is joined directly to the amino terminus of the stress protein
GB9723630D0 (en) * 1997-11-07 1998-01-07 Stanford Rook Ltd M.vaccae preparation and its use
RU2137137C1 (ru) * 1997-12-03 1999-09-10 Научно-исследовательский институт по изучению лепры Способ определения m.leprae у больных с регрессом заболевания
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
CA2315539A1 (fr) * 1997-12-23 1999-07-01 Genesis Research & Development Corporation Limited Compositions derivees de mycobacterium vaccae et leurs methodes d'utilisation
US6497880B1 (en) 1998-12-08 2002-12-24 Stressgen Biotechnologies Corporation Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
GB9903539D0 (en) * 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
JP2003504074A (ja) 1999-07-08 2003-02-04 ストレスゲン バイオテクノロジーズ コーポレイション インビトロでのＴｈ１様応答の誘導
AU6896300A (en) * 1999-08-06 2001-03-05 Corixa Corporation Vaccines for the treatment of autoimmune disease
CA2396384A1 (fr) 2000-01-14 2001-07-19 Whitehead Institute For Biomedical Research L'elicitation in vivo des ctl par des proteines de fusion de la proteine de choc thermique correspond a un domaine discret de liaison de l'atp et est independante des cellules cd4+
NZ523408A (en) 2000-06-26 2006-02-24 Stressgen Biotechnologies Corp Human papilloma virus treatment
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
KR20030074787A (ko) 2001-02-05 2003-09-19 스트레스젠 바이오테크놀러지스 코포레이션 Ｂ형 간염 바이러스 치료
GB0106987D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeuitic agent
WO2003063759A2 (fr) 2002-01-31 2003-08-07 Peptor Ltd. Peptides de hsp et analogues pour la modulation des reponses immunitaires par l'intermediaire des cellules presentant l'antigene
EP1835933A4 (fr) 2005-01-04 2015-01-07 Yeda Res & Dev Hsp60, peptides hsp60 et vaccins a base de lymphocytes t pour immunomodulation
GB0526033D0 (en) * 2005-12-21 2006-02-01 Bioeos Ltd Method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487198A1 (fr) * 1980-07-28 1982-01-29 Berri Balzac Sa Nouvelle substance immuno-suppressive, son procede d'isolement et son application en therapeutique
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
NL8701163A (nl) * 1986-09-09 1988-04-05 Nederlanden Staat Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits.
NL8703107A (nl) * 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
GB8917256D0 (en) * 1989-07-28 1989-09-13 Univ London Biological preparation and its use
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene

Also Published As

Publication number Publication date
AU644813B2 (en) 1993-12-23
ATE135588T1 (de) 1996-04-15
DK0489072T3 (da) 1996-04-15
DE69026094D1 (de) 1996-04-25
NO920722D0 (no) 1992-02-24
CA2065286A1 (fr) 1991-02-26
GB2252044A (en) 1992-07-29
EP0489072A1 (fr) 1992-06-10
EP0489072B1 (fr) 1996-03-20
JPH05501870A (ja) 1993-04-08
FI920795A7 (fi) 1992-02-24
FI920795A0 (fi) 1992-02-24
JP2987197B2 (ja) 1999-12-06
WO1991002542A1 (fr) 1991-03-07
US5833996A (en) 1998-11-10
DE69026094T2 (de) 1996-08-22
CA2065286C (fr) 2000-05-16
GB8919321D0 (en) 1989-10-11
GB9203904D0 (en) 1992-04-15
ZA906753B (en) 1991-06-26
GB2252044B (en) 1993-09-22
AU6289790A (en) 1991-04-03

Similar Documents

Publication Publication Date Title
NO920722L (no) Fremgangsmaate ved behandling av kroniske inflammatoriske lidelser
NO871512L (no) Kontinuerlig fremgangsmaate for tablettering og apparat for utfoerelse av fremgangsmaaten.
DK0396404T3 (da) Farmaceutisk middel indeholdende loratadin, ibuprofen og pseudoephedrin
NO870819L (no) FremgangsmŸte, system og apparat ved intravaskulŸr ultralyd-billeddannelse.
JPS52108692A (en) Adjusting device for joint portion of medical treatment or examination apparatus
DK524483D0 (da) Fremgangsmade og apparat til at diagnosticere oeresygdomme
DK389889D0 (da) Fremgangsmaade og apparat til estimering af legemskonturer i viftestraaleberegnede tomografisystemer
Lamb Prognosis for the infertile couple
NO873074D0 (no) Fremgangsmaate og apparat for fremstilling av spiralsnodde roerknipper.
IT8124060A0 (it) Apparecchiatura a raggi x per panorama tomografico particolarmente per la radiografia della regione cranica e del collodi un paziente disteso.
ES532286A0 (es) Metodo in vitro para detectar un estado maligno en un paciente humano.
Mortensen et al. Ventilation tubes and cholesteatoma in children
IT1126572B (it) Derivato del paracetamol,procedimento per la sua preparazione e suo impiego nel campo terapeutico
Lopez Tuberculosis and the severely mentally ill.
FR2585710B1 (fr) Copolymere hydrophile convenant surtout aux lentilles de contact et aux applications medicales, et procede pour sa preparation
IE830340L (en) Apparatus for evacuating immobile patients from hospitals
IT7821559A0 (it) Impianto endoosseo individuale perfezionato per odontostomatologia (chirurgia della bocca) eprocedimento per la sua rapida e perfetta applicazione al paziente.
Babich et al. Heat Treatment of Railroad Rails
SU586577A1 (ru) Контактное устройство
FR2376656A1 (fr) Appareil pour le traitement chirurgical des os et des articulations
Nagasawa Placing More Emphasis on Physiological Examinations
McGuinness The health of sterilized women
SHIGEMATSU et al. Three cases of facial prosthesis
Landay Immune restoration following treatment
SU693470A1 (ru) Устройство дл вакуумной обработки электровакуумных приборов